Tecovirimat

Edina Avdic, Pharm.D.
Tecovirimat is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 13 kg.
    • Limitation of use:
      • Effectiveness of tecovirimat treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical.
      • Efficacy may be reduced in immunocompromised patients based on animal models.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: September 6, 2019